e-learning
resources
Virtual 2020
Pre-Congress Content
Biological mechanisms of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of PD-L2 on macrophages in lung cancer milieu- pilot study.
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), M. Polubiec-Kownacka (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)
Source:
Virtual Congress 2020 – Biological mechanisms of lung cancer
Session:
Biological mechanisms of lung cancer
Session type:
E-poster session
Number:
1767
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), M. Polubiec-Kownacka (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland). Identification of PD-L2 on macrophages in lung cancer milieu- pilot study.. 1767
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
The role of CD40 molecule in human lung cancer and its application in immunotherapy
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003
Tumour-associated macrophages in nonsmall cell lung cancer: the role of interleukin-10
Source: Eur Respir J 2007; 30: 608-610
Year: 2007
The clinical significance of CD40 molecule expressed on human lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 394s
Year: 2003
Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses tumor-specific T cell immunity
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer?
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Expression of PD1, COPD and lung cancer.
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
The expression and clinical significance of PD-L1
+
CD68
+
macrophages in peripheral blood mononuclear cells of non-small cell lung cancer
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Adipocyte-derived exosomes promote lung cancer metastasis byincreasing MMP9 activity via transferring MMP3 to lung cancer cells
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
LSC - 2017 - Tumor-associated macrophages promote inflammasome-dependent lung tumor progression in mice
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Decreased reactivity of the alveolar macrophages in relation to ICAM-1 expression after IFNγ stimulation in lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 276s
Year: 2002
LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016
Microbial analysis in lung cancer according to PD-L1 level and immunotherapy response
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Role of EBUS-TBNA in the study of PD-L1 expression in patients with non-small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Endobronchial ultrasound: from rookie to pro
Year: 2020
Implementation of PD-L1 analysis among patients with non-small cell lung cancer in a single center.
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003
The expression of PD-L1 on the lung cancer cell and its role in T cell anergy
Source: Eur Respir J 2007; 30: Suppl. 51, 289s
Year: 2007
PD-L1 expression on alveolar macrophages and in plasma of IPF patients – original research
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
TERT expression in lung cancer associated with IPF: a case-control study
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Reduced expression of CD44 on lung macrophages from patients with COPD
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
PD-L1 expression on lung cancer stem cells in metastatic lymph nodes.
Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept